These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26111939)

  • 1. A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.
    Carter BL; Coffey CS; Chrischilles EA; Ardery G; Ecklund D; Gryzlak B; Vander Weg MW; James PA; Christensen AJ; Parker CP; Gums T; Finkelstein RJ; Uribe L; Polgreen LA;
    Pharmacotherapy; 2015 Jul; 35(7):653-62. PubMed ID: 26111939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A centralized cardiovascular risk service to improve guideline adherence in private primary care offices.
    Carter BL; Levy BT; Gryzlak B; Chrischilles EA; Vander Weg MW; Christensen AJ; James PA; Moss CA; Parker CP; Gums T; Finkelstein RJ; Xu Y; Dawson JD; Polgreen LA
    Contemp Clin Trials; 2015 Jul; 43():25-32. PubMed ID: 25952471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.
    Carter BL; Levy B; Gryzlak B; Xu Y; Chrischilles E; Dawson J; Vander Weg M; Christensen A; James P; Polgreen L
    Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004188. PubMed ID: 29884657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissemination of a telehealth cardiovascular risk service: The CVRS live protocol.
    Kennelty KA; Engblom NJ; Carter BL; Hollingworth L; Levy BT; Finkelstein RJ; Parker CP; Xu Y; Jackson KL; Dawson JD; Dorsey KK
    Contemp Clin Trials; 2021 Mar; 102():106282. PubMed ID: 33444781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.
    Carter BL; Clarke W; Ardery G; Weber CA; James PA; Vander Weg M; Chrischilles EA; Vaughn T; Egan BM;
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):418-23. PubMed ID: 20647575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.
    Gilani F; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH
    Ann Pharmacother; 2013 Jan; 47(1):43-8. PubMed ID: 23324512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
    Lee JK; Grace KA; Taylor AJ
    JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.
    Carter BL; Coffey CS; Ardery G; Uribe L; Ecklund D; James P; Egan B; Vander Weg M; Chrischilles E; Vaughn T
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):235-43. PubMed ID: 25805647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol.
    Lasser KE; Shanahan C; Parker V; Beers D; Xuan Z; Heymann O; Lange A; Liebschutz JM
    J Subst Abuse Treat; 2016 Jan; 60():101-9. PubMed ID: 26256769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care (protocol).
    Koelewijn-van Loon MS; van Steenkiste B; Ronda G; Wensing M; Stoffers HE; Elwyn G; Grol R; van der Weijden T
    BMC Health Serv Res; 2008 Jan; 8():9. PubMed ID: 18194522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
    Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
    BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services.
    Tu JV; Chu A; Donovan LR; Ko DT; Booth GL; Tu K; Maclagan LC; Guo H; Austin PC; Hogg W; Kapral MK; Wijeysundera HC; Atzema CL; Gershon AS; Alter DA; Lee DS; Jackevicius CA; Bhatia RS; Udell JA; Rezai MR; Stukel TA
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):204-12. PubMed ID: 25648464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a clinical pharmacy anemia management service on adherence to monitoring guidelines, clinical outcomes, and medication utilization.
    Debenito JM; Billups SJ; Tran TS; Price LC
    J Manag Care Spec Pharm; 2014 Jul; 20(7):715-20. PubMed ID: 24967524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS; D'Souza JJ; Rihani RS
    J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial.
    Jakobsson S; Huber D; Björklund F; Mooe T
    BMC Cardiovasc Disord; 2016 Apr; 16():77. PubMed ID: 27129980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in safety monitoring of biologic response modifiers after the implementation of clinical care guidelines by a specialty.
    Hanson RL; Gannon MJ; Khamo N; Sodhi M; Orr AM; Stubbings J
    J Manag Care Pharm; 2013; 19(1):49-67. PubMed ID: 23383700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.